Life Sciences Issues for a Mission to Mars by unknown
MP5: Life Sciences IssuesJor a Mission to Mars 
Monday, June 9 
Session MP5 
RoomS 
2:30 - 5:30 p.m. 
,:5S--S/ 
cJ 7:? ~3~ 
~) f, 
Life Sciences Issues for a Mission 
to Mars 
38 
https://ntrs.nasa.gov/search.jsp?R=19980024344 2020-06-16T00:52:47+00:00Z
MP5: Life Sciences Issues/or a Mission to Mars 
CARDIOVASCULAR CONCERNS FOR A MARS MISSION: 
AUTONOMIC AND BIOMECHANICAL EFFECTS 
ID. D'aunno, 2J. Yelle, 3G. Pantalos, 4T. Brown 
INASA-JSC/uTMB/uSRA-CASS Houston, TX 
2NASA-JSC Houston, TX 
3Univ. of Utah Salt Lake City, UT 
4KRUG Life Sciences Houston, TX 
INTRODUCTION 
From the perspective of the cardiovascular system there seems limited concern that the crew could 
survive the exposure to weightlessness necessary to achieve a Mars destination. The greatest obstacle extant 
is to deliver a crew to the surface, possessing a functional capacity permitting routine and emergency 
operations once planetfall is achieved. 
Within moments of entering weightlessness, the cardiovascular system begins responding to the 
new environment. Altered baseline physiologic parameters have consistently been observed in flight. To 
date, these have not proved to impact adversely on mission objectives. However, the exact mechanism 
effecting these changes are not completely understood. A relatively stable steady-state is achieved in the 
short term. With longer duration missions, there has been some evidence of increased ventricular and 
supraventricular ectopy, the basis of which is unknown. Possible explanations include electrolyte 
abnormalities, autonomic dysfunction, hormonal influences and/or mechanical alterations. The 
cardiovascular response to stress and exertion is different in longer duration flights. These alterations have 
not become clinically significant nor have they hindered mission objectives. With missions of even greater 
duration planned however, these physiologic changes become a point of great concern. Not enough 
information is available to adequately predict long term cardiovascular changes and the health impact on the 
crew. 
RESULTS 
Crews returning to Earth from short and long duration space flights have demonstrated a reversible 
form of autonomic dysfunction. Recent studies have suggested that this is a major component of the 
sometimes severe orthostatic intolerance and syncope experienced by crew members once they return to 
gravity'S domain. Too little is understood about the autonomic nervous system and its influence on 
cardiovascular fitness to predict what long term consequences would be, once this system is perturbed from 
long duration exposure to weightlessness. 
An artificial cardiovascular system has been developed to observe the biomechanical effects of 
microgravity isolated from the autonomic/nervous influences. Results of parabolic flight-induced 
microgravity experiments, which segregate the vascular and ventricular contractile and compliance forces and 
pressures from inherent cardiovascular reflexes, will be discussed. 
CONCLUSION 
Incomplete knowledge of the mechanisms effecting cardiovascular change is a significant obstacle 
in devising effective countermeasures. Interventions should be developed to ensure a degree of cardiovascular 
fitness sufficient to permit crews landing on Mars the ability to rapidly carry out mission objectives and be 
able to negotiate any emergency situations that arise. 
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REDUCING THE RISK OF SPACE RADIATION INDUCED BIOEFFECTS-
VEHICLE DESIGN AND PROTECTANT MOLECULES 
M. Stanfordl , J. Jones2, H.Lane3, P.Riggs3, T.Yang3 
lCenter for Aerospace Medicine and Physiology, Galveston, TX 
2NASNJSC, USRNCASS, UTMB- Houston, Galveston TX 
3NASNJSC Houston, TX 
ENVIRONMENT 
The space environment poses many significant challenges to mission planners of exploratory class 
missions to the moon and Mars. Radiation exposures received by the crew and spacecraft are a function of 
the location (LEO, free space, planetary surface), the time of flight with respect to the Solar Cycle, and 
whether or not solar particle events are being experienced in each of these different environments. Current 
knowledge of these different environments have uncertainties in the range of 2 to 4 times actual values. 
These uncertainties need to be reduced for proper mission planning and risk amelioration for exploratory 
class space flight. 
SPACECRAFT DESIGN 
Risk assessment must deal with biological impacts associated with human exposure to the space radiation 
environment as well as potentially harmful effects to spacecraft electronic systems due to damaging 
interactions with the space particulate radiation. Additionally, spacecraft design must use mass effectively 
to provide adequate shielding of crew and components during the long duration flight times envisioned in 
the exploratory class flight scenarios. 
BIOEFFECT MODULATION 
Space radiation bioeffects are often described both in terms of dose delivery to the organism: acute high dose 
vs. chronic low dose, as well as by the source of emanation: galactic cosmic rays(GCR) vs. Solar Particle 
Events(SPE's). Characterizing both the quality and quantity of radiation expected along the planned transfer 
route and on the Martian surface, is paramount in defining the radiation exposure risk. Developing improved 
measurement models( e.g. via onboard active dosimeters) for predicting SPE exposure and intervention 
strategies will also prove to be invaluable in a Mars mission. Shielding design may lower the crew's 
exposure and thus their chances of developing acute radiation sickness resulting from the delivery of a 
greater than 300 rem dose that might be expected from a high fluence SPE. However, the stochastic effects 
such as carcinogenesis, resulting from a long term exposure to daily GCR or from the secondary radiation 
events produced by HZE particle fragmentation by spacecraft shielding in deep space, may not have been 
adequately studied or mitigated to date. A number of radioprotectant molecules have been evaluated in the 
past, mainly by groups interested in lessening the effects on humans of nuclear explosions or therapeutic 
radiation for cancer treatment. Although some of these agents have been shown to reduce radiation toxicity, 
their side effects and delivery mode have limited their potential utility for flight crews. Newer, less toxic 
agents are showing promise in lessening the effects of ionizing radiation on eukaryotic DNA and cellular 
processes. 
DISCUSSION 
This session will discuss current thinking on the space radiation issue as well as pose some interesting 
ideas concerning the future work required in a radiation health/assessment program. Data shows that 
shielding effectiveness of certain materials, such as hydrogen and water, will impact the final design of an 
exploratory spacecraft to best utilize these materials in the overall shielding strategy(see Figure). Also 
strategies for potential reduction of bioeffects by molecules designed to limit the impact of ionizing 
radiation on mammalian cells will be discussed. 
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GALACTIC COSMIC RAYS - SOLAR MINIMUM 
(Depth vs. Dose Functions for Selected Materials) 
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MUSCULOSKELETAL ISSUES FOR LONG DURATION MISSION: 
MUSCLE MASS PRESERVATION, RENAL STONE RISK FACTORS, 
COUNTERMEASURES, AND CONTINGENCY TREATMENT PLANNING 
P .Hilliard 1, J.J ones 1 
R. Pietrzyk2, P.Whitson3 
INASAlJSC, UTMB, USRAICASS, Houston, Galveston, TX 
2KRUG Life Sciences, Houston, TX 
3NASAlJSC, Houston, TX 
INTRODUCTION 
One of the greatest physiologic challenges to long duration space flight is the maintainance of muscle mass 
and bone density. This would be especially true for a crew who would be required to rapidly establish a life 
support base on the Martian surface following an extended time in microgravity. Muscle atrophy and 
weakness occur even on short duration shuttle flights of 10-16 days duration. A greater effect is seen with 
extended stays in LEO. The potential consequences of bone and muscle weakness include inabilty to 
egress(in nominal and contigency situations), increased orthostatic intolerance, bone fractures, muscle 
injury, hypercalcemia, urinary lithiasis. With planned extended stay missions to orbiting space stations and 
potentially manned missions to Mars, there has been a concentrated effort to develop countermeasures to 
prevent bone and muscle loss. 
Significant physiological changes occur in astronauts upon exposureto micro gravity and the readaptation 
process that follows their return to Earth. Some well-documented changes that result from space flight, 
including increased urinary calcium and phosphorus excretion and decreased fluid intake/urine output, result 
in a urinary chemical environment in which there is a greater risk of renal stone formation. 
RESULTS 
Our studies have indicated that risk factors in addition to those previously anticipated contribute to an 
increased risk for renal stone formation during and after space flight. In particular, low urinary pH and 
hypocitraturia increase the renal stone-forming risk of uric acid and calcium-containing stones. Immediately 
after space flight the relative supersaturation for uric acid or calcium oxalate is greater than 2 times a normal 
non-stone forming population. During space flight, the risk is significantly elevated for calcium oxalate 
and brushite stones. These alterations in risk factors are reversible 7-14 days after return to Earth. 
Duration of space flight has not indicated greater risk as a function of mission duration; in general, the data 
are consistent for long and short duration space flights. Urine volumes greater than 2 liter/day were found 
to reduce the risk of stone formation in astronauts immediately after space flight as compared to those 
astronauts with urine volumes less than 2liters/day. Although urine volume appears to be sufficient as a 
countermeasure to reduce stone~forming potential immediately after flight when the body is readapting to 
the Earth environment, hydration as a countermeasure may not be sufficient to reduce stone formation 
during flight where hypercalciuria and hypocitraturia are an ongoing problem. (See Table 1) 
DISCUSSION 
The panel will present an overview of the findings of countermeasure studies to date and discuss current and 
future countermeasure strategies for long duration space flight. Potential countermeasures for maintaining 
musular and skeletal integrity include various resistance and endurance exercise regimens, and augmentation 
of these protocols with drugs, "penguin suits", or electrical stimulation. The potential of utilizing oral 
potassium citrate therapy will be discussed as a countermeasure to reduce renal stone formation during space 
flight. Finally potential contingency stone management strategies will be outlined. 
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Table 1. Renal Stone Risk in Astronauts Before, During and After Space Flight. 
Group 1 Group 2 
PRE POST PRE IN-FLT POST 
(n=279) (n= 6) 
Calcium (mg/day) 191 (5.8) 241 (7.2)* 166 (32.7) 132 (22.0) 222 (34.4) 245 (70.2)* 
Total Volume (Vday) 2.01 (0.06) 1.94 (0.06) 1.68 (0.09) 0.80 (0.08) 1.30 (0.17) 1.52 (0.35) 
pH 6.01 (0.03) 5.68 (0.03)* 6.01 (0.18) 5.95 (0.19) 5.92 (0.13) 5.14 (0.05)* 
Citrate (mg/day) 708 (17.5) 609 (19.1)* 718(115) 469 (109) 522 (66) 456 (82) 
Urinary Relative Supersaturation 
Calcium Oxalate 1.64 (0.06) 2.32 (0.06)* 1.52 (0.40) 2.95 (0.65)* 2.78 (0.47)* 2.07 (0.40) 
Brushite 1.35 (0.07) 0.98 (0.06) 1.11 (0.32) 2.20 (0.32)* 2.10 (0.43)* 0.32 (0.07) 
Sodium Urate 2.71 (0.14) 1.48 (0.08) 1.83 (0.47) 2.66 (0.50) 1.77 (0.42) 0.66 (0.42) 
Struvite 2.04 (0.37) 0.56 (0.08) 1.29 (0.78) 3.46 (1.44) 0.99 (0.28) 0.05 (0.04) 
Uric Acid Saturation 1.95 (0.10) 2.69 (0.11)* 1.96 (0.69) 2.31 (0.75) 1.68 (0.31) 2.84 (0.76) 
For Group 1. the data represent the mean +/- sem obtained 10 days prior to launch (PRE) and on landing day (POST). 
For Group 2, the values for PRE are the means +/- sem from two separate preflight urine collections. In-Fit represents 
two separate urine collections during the early phase of the missions (flight days 3-4) and during the late phase of the 
mission (flight days 11-13). * denotes significant differences from before flight, p < 0.05. 
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PSYCHOLOGICAL ISSUES AND 
CREW SELECTION FOR A MARS MISSION: 
MAXIMIZING THE MIX FOR THE LONG HAUL 
IS. Bishop, 2J. Wood, 3J. Jones 
lCenter for Aerospace Medicine and Physiology/uTMB Galveston, TX 
2KRUG Life Sciences Houston, TX 
3NASAlJSC, UTMB, USRAICASS Houston, Galveston TX 
INTRODUCTION 
Historically, the process of mission specific crew selection for space flights has been severely limited. 
Mainly oriented towards ruling out pathology and maximizing specific field-relevant expertise, all other 
factors (e.g., gender, race, culture) have oftentimes been driven by political processes rather than attention to 
maximizing team processes. 
RESULTS 
Growing evidence from psychosocial research and a body of experience with long-term exposure to 
the space environment, indicate that the time has come to move towards identifying those individuals who 
are best suited to maintain maximal health and performance under conditions characterized by close 
confinement, reduced stimulation, weightlessness, isolation and extreme environmental danger. Evidence 
has clearly indicated problematic areas in which group functioning has been compromised to some extent by 
the presence of communication breakdowns, interpersonal conflict, individualized responses to 
environmental stresses and conflicts over authority and control. A renewed focus on psychosocial factors is 
beginning to yield information regarding crew size, gender mix, composition, structure and the necessary 
interpersonal skills required for effective group performance in extreme environments. 
Lessons learned from military and remote outpost team member observational studies indicate that the 
pressures on individuals required to work and live together in extreme environments, could raise the need to 
address personality and behavior issues, not otherwise required in more limited missions. Group living 
training pre-flight may playa role in providing crew members with a variety of coping skills and strategies 
to effectively handle these personalitylbehavioral issues as they arise. Further research on the role of pre-
flight mission simulation with proposed crews may provide insight into the factors predicting potential 
interpersonal conflicts during the mission. Mental health monitoring tools need to be developed that provide 
real-time assessment of behavioral conflicts and possible secondary somatization symptomatology. 
Defining resources that crews may have for intervention during periods of defined stress may prove 
invaluable for maximizing crew performance. 
DISCUSSION 
Pertinent issues for guiding psychological and behavioral factors in crew selection for long-duration 
missions will be discussed. Mental health monitoring and support strategies will be evaluated. Finally 
discussion will be made of interactive psychological appraisal tools used in monitoring assigned crews in 
the Antarctic and remote outposts. 
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ISSUES IN CREW HEALTH, MEDICAL SELECTION AND MEDICAL 
OFFICER(CMO) TRAINING FOR A MISSION TO MARS 
Ie. Jernigan, 2B. Harris, IR. Jennings 
ICenter for Aerospace Medicine and Physiology, UTMB, Galveston, TX 
2Spacehab, Houston, TX 
Crew medical selection criteria and plans for medical care should both derive from mission 
guidelines defining acceptable risk. Acceptable risk for events affecting mission completion, and for events 
affecting individual career completion should both be given proper weight. Low earth orbital missions and 
interplanetary missions expose crew members to categorically similar risks; but markedly increased return 
times and the absence of radiation shielding provided by Earth's magnetosphere greatly increase the 
magnitude of some categories of risk. These risks can be ameliorated by careful attention to habitat design, 
medical selection criteria, onboard medical capability and remote medical consultation capability. Habitat 
design must be carefully analyzed and incorporated into spacecraft design at the earliest stages in order to 
achieve the best costlbenefit ratio. Mission duration significantly influences the appropriate mix of medical 
personnel training, experience and skill and knowledge redundancy. Interplanetary communication lag times 
impose significant limitations on the use of earth based consultation. A discussion of needed Crew Medical 
Officer credentials, experience, and training in order to effectively liaison with ground-based flight surgeons 
will be conducted. 
A Crew Health Maintenance Plan including transfer and surface requirements will be outlined. 
Special problems associated with medical diagnostics and treatment associated with potential lowered 
gravity environments will be discussed. Also included will be a summary of circadian physiology, crew rest 
and possible pharmacological and light-based countermeasures. 
45 
